CSTL Stock Analysis: Buy, Sell, or Hold?
CSTL - Castle Biosciences, Inc. Common Stock
$24.84
-0.21 (-0.84%)
▼
5d:
+0.57%
30d:
-11.82%
90d:
-36.14%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 04, 2026
Get Alerted When CSTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CSTL shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CSTL shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CSTL is currently trading at $24.84, which is considered slightly low relative to its 30-day fair value range of $24.53 to $28.65.
Technical Outlook: Technically, CSTL is in a strong downtrend. Immediate support is located at $23.24, while resistance sits at $26.19.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $48.50 (+93.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CSTL is in a strong downtrend. Immediate support is located at $23.24, while resistance sits at $26.19.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $48.50 (+93.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$24.53 -
$28.65
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 93.6% below Wall St target ($48.50)
Fair Price Analysis
30-Day Fair Range
$24.53 -
$28.65
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.24
Resistance Level
$26.19
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-46.06
Wall Street Target
$48.50
(+93.6%)
Revenue Growth (YoY)
0.8%
Earnings Growth (YoY)
-51.6%
Profit Margin
-7.0%
Share & Embed Analysis
Last updated: April 02, 2026 2:05 PM ET
Data refreshes hourly during market hours. Next update: 3:05 PM
Data refreshes hourly during market hours. Next update: 3:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CSTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Tobin W Juvenal
SELL
20863 shares
2026-03-12
Frank Stokes
SELL
6001 shares
2026-03-05
G Bradley Cole
SELL
7403 shares
2026-03-05
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 67 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 62 BUY |
